(Q42235631)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Manuel A F V Gonçalves

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Maarten Holkers

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

20 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

179-187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

Genome Engineering With Zinc-Finger Nucleases

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Optimizing delivery and expression of designer nucleases for genome engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

An unbiased genome-wide analysis of zinc-finger nuclease specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Knockout rats generated by embryo microinjection of TALENs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

TALENs: a widely applicable technology for targeted genome editing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Breaking the code of DNA binding specificity of TAL-type III effectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

A simple cipher governs DNA recognition by TAL effectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

A ligation-independent cloning technique for high-throughput assembly of transcription activator–like effector genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

FLASH assembly of TALENs for high-throughput genome editing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Adenovirus: from foe to friend.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Additional serotypes of the APC virus group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Adenovirus receptors: implications for targeting of viral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

CD46 is a cellular receptor for group B adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

An adenovirus traffic update: from receptor engagement to the nuclear pore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Biosafety of adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Current advances and future challenges in Adenoviral vector biology and targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Optimization of scarless human stem cell genome editing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Preassembled zinc-finger arrays for rapid construction of ZFNs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

Quantitation of adenovirus DNA and virus particles with the PicoGreen fluorescent Dye.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2014.02.017

10.1016/J.YMETH.2014.02.017

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24561826%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference